1. Efficacy and challenges of anti-PD1 in MSI-H mCRC: a case report on concurrent infections and ir-AIHA
   Xiaxia Pei et al, 2024, Frontiers in Oncology CrossRef
2. Microsatellite instability: A potential game-changer in colorectal cancer diagnosis and treatment
   Rehanoddin Shaikh et al, 2024, Results in Chemistry CrossRef
3. Immunotherapy with Immune Checkpoint Inhibitors for Advanced Colorectal Cancer: A Promising Individualized Treatment Strategy
   Ying Yang et al, 2023, Frontiers in Bioscience-Landmark CrossRef
4. Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer
   Mayur M. Amonkar et al, 2023, Cancer Treatment and Research Communications CrossRef
5. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer
   Pengcheng Wang et al, 2024, ACS Biomaterials Science & Engineering CrossRef
6. Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review
   Ioannis M. Koukourakis et al, 2023, Current Issues in Molecular Biology CrossRef
7. Colitis-associated carcinogenesis: crosstalk between tumors, immune cells and gut microbiota
   Junshu Li et al, 2023, Cell & Bioscience CrossRef
8. Personalised neoantigen‐based therapy in colorectal cancer
   Ya‐Juan Zhu et al, 2023, Clinical and Translational Medicine CrossRef
9. Advancements in Cytological Techniques in Cancer
   Cristina Díaz del Arco et al, 2024, Handbook of Cancer and Immunology CrossRef